Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.
Yu C, Luo D, Yu J, Zhang M, Zheng X, Xu G, Wang J, Wang H, Xu Y, Jiang K, Xu J, Ma X, Jing J, Shi H.
Yu C, et al. Among authors: xu g, xu y, xu j.
Oncogene. 2022 Jan;41(2):191-203. doi: 10.1038/s41388-021-02077-w. Epub 2021 Oct 30.
Oncogene. 2022.
PMID: 34718347
Free PMC article.